Literature DB >> 19714796

Orbscan II anterior elevation changes following corneal collagen cross-linking treatment for keratoconus.

Kyaw Lin Tu1, Ioannis M Aslanides.   

Abstract

PURPOSE: To analyze anterior corneal elevation changes on Orbscan II following corneal collagen cross-linking (CXL) with riboflavin.
METHODS: This retrospective study included 8 patients (14 eyes) with keratoconus who underwent CXL, with a mean follow-up of 7 months (range: 5 to 10 months). Pre- and postoperative (at last clinic attendance) anterior elevation difference maps were examined for overall patterns of change. On preoperative maps, distances from maximum anterior elevation to pupil center and to topographic geometric center were compared between the two patterns identified. Pre- and postoperative topography, best spectacle-corrected visual acuity (BSCVA), and refraction were also compared between the two patterns.
RESULTS: Two patterns of anterior elevation change were visually identified: (1) paracentral steepening, no change, or flattening centrally; and (2) central steepening. The preoperative maps of eyes that manifested pattern 1 had shorter mean distances for maximum anterior elevation to pupil center (1.70 vs. 2.27 mm) and maximum anterior elevation to geometric center (1.45 vs. 1.99 mm) than those that resulted in pattern 2. Mean maximum topographic simulated keratometry decreased (P = .004) and mean irregularity indices at 3 mm (P =.03) and 5 mm (P =.04) were reduced postoperatively in pattern 1 eyes; all increased in pattern 2 eyes. Mean BSCVA improved postoperatively for both patterns. Mean preoperative myopia decreased in pattern 1 eyes by 0.44 diopters (D), whereas it increased for pattern 2 eyes by 1.83 D.
CONCLUSIONS: Corneal shape change influenced by anisotropy of collagen distribution is a factor in the outcome of CXL treatment for keratoconus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19714796     DOI: 10.3928/1081597X-20090707-06

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  8 in total

1.  A short-term study of corneal collagen cross-linking with hypo-osmolar riboflavin solution in keratoconic corneas.

Authors:  Shao-Feng Gu; Zhao-Shan Fan; Li-Hua Wang; Xiang-Chen Tao; Yong Zhang; Chun-Qin Wang; Ya Wang; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

2.  Femtosecond-assisted intrastromal corneal cross-linking for early and moderate keratoconus.

Authors:  M Balidis; V E Konidaris; G Ioannidis; A J Kanellopoulos
Journal:  Eye (Lond)       Date:  2014-07-25       Impact factor: 3.775

3.  Patient-specific computational modeling of keratoconus progression and differential responses to collagen cross-linking.

Authors:  Abhijit Sinha Roy; William J Dupps
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

Review 4.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

Review 5.  Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus.

Authors:  Z Shalchi; X Wang; M A Nanavaty
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

6.  Corneal changes following collagen cross linking and simultaneous topography guided photoablation with collagen cross linking for keratoconus.

Authors:  Prema Padmanabhan; Aishwaryah Radhakrishnan; Abinaya Priya Venkataraman; Nidhi Gupta; Bhaskar Srinivasan
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

7.  Transepithelial photorefractive keratectomy with crosslinking for keratoconus.

Authors:  Achyut N Mukherjee; Vasilis Selimis; Ioannis Aslanides
Journal:  Open Ophthalmol J       Date:  2013-10-18

8.  Transepithelial Corneal Cross-Linking With Vitamin E-Enhanced Riboflavin Solution and Abbreviated, Low-Dose UV-A: 24-Month Clinical Outcomes.

Authors:  Ciro Caruso; Carmine Ostacolo; Robert L Epstein; Gaetano Barbaro; Salvatore Troisi; Decio Capobianco
Journal:  Cornea       Date:  2016-02       Impact factor: 2.651

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.